Avon Anew Clinical, Cellu-Sculpt Drive Q3 Skin Care Sales Growth
This article was originally published in The Rose Sheet
Executive Summary
Avon's U.S. skin care business advanced 22% in the third quarter, boosted in part by the strong debut of Anew Clinical, President and Chief Operating Officer Susan Kropf said during an Oct. 28 analyst call
You may also be interested in...
Avon guidance
Q4 sales expected to grow 13% in dollars, and be up "high single digits" excluding the impact of foreign exchange, Avon announces Dec. 8 in guidance revision. Performance will be fueled by 16% jump in beauty product sales and 9% increase in the number of active representatives, direct-seller states. Avon also expects earnings to be $1.03-$1.04 per share, "with the upside driven by a gain of approximately $.05 per share from a tax settlement expected to be finalized this month," firm says. U.S. sales will be up low-to-mid single digits, lower than originally anticipated due in part to weak fragrance promotions. Teen brand Mark expected to contribute 1% to overall U.S. sales growth. Full year earnings will be around $2.72 per share, versus earlier estimates of $2.65-$2.70 (1"The Rose Sheet" Nov. 3, 2003, p. 6)...
Avon guidance
Q4 sales expected to grow 13% in dollars, and be up "high single digits" excluding the impact of foreign exchange, Avon announces Dec. 8 in guidance revision. Performance will be fueled by 16% jump in beauty product sales and 9% increase in the number of active representatives, direct-seller states. Avon also expects earnings to be $1.03-$1.04 per share, "with the upside driven by a gain of approximately $.05 per share from a tax settlement expected to be finalized this month," firm says. U.S. sales will be up low-to-mid single digits, lower than originally anticipated due in part to weak fragrance promotions. Teen brand Mark expected to contribute 1% to overall U.S. sales growth. Full year earnings will be around $2.72 per share, versus earlier estimates of $2.65-$2.70 (1"The Rose Sheet" Nov. 3, 2003, p. 6)...
Anew Clinical Offers Collagen, Elastin, Hydro-Protein Benefits, Avon Says
Avon's Anew Clinical Line and Wrinkle Corrector will bow in September as the flagship product in a new anti-aging skin care range, the direct-seller stated